Close Menu

NEW YORK – Exact Sciences reported after the close of the market on Thursday that its second quarter revenues rose 35 percent year over year, despite a 34 percent decrease in screening product revenues.

For the three months ended June 30, the Madison, Wisconsin-based molecular diagnostics company reported revenues of $268.9 million, up from $199.9 million a year earlier, beating the average Wall Street estimate of $228.4 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.